Immediate measures
If a transfusion-associated adverse reaction is suspected, the following immediate measures are initiated:
- Interruption or discontinuation of the transfusion
- Leave access in place
- Symptomatic therapy according to the Clinical Department
- Identification of the patient
- Documentation on the accompanying bill for blood components
- Initiate clarification of the transfusion reaction (transfusion reaction request card)
- Sampling for laboratory tests and immediate forwarding to the ITM
- Assessment of the connection with the transfusion